Automated Immunoassay Analyzers Market Size, Share | 2023 – 2032

Automated Immunoassay Analyzers Market - By Product (Immunofluorescence, Chemiluminescence, ELISA), By Application (Infectious Diseases, Endocrinology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories), & Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Automated immunoassay analyzers industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Product trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Automated Immunoassay Analyzers Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Incessant introduction of advanced products

3.2.1.2&nbsp;&nbsp;&nbsp;Rising trend towards lab automation

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing prevalence of infectious diseases

3.2.1.4&nbsp;&nbsp;&nbsp;Expanding clinical applications of immunoassay analyzers

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Dearth of qualified and trained professionals

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.5.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Automated immunoassay analyzers product outline

3.8&nbsp;&nbsp;&nbsp; Technology landscape

3.9&nbsp;&nbsp;&nbsp; Global market share analysis, by settings and application

3.10&nbsp;&nbsp;&nbsp; Gap analysis

3.11&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.12&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4.1&nbsp;&nbsp;&nbsp; Global

4.4.2&nbsp;&nbsp;&nbsp; North America

4.4.3&nbsp;&nbsp;&nbsp; Europe

4.4.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.4.5&nbsp;&nbsp;&nbsp; Latin America

4.4.6&nbsp;&nbsp;&nbsp; MEA

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Automated Immunoassay Analyzers Market Size and Forecast, By Product (USD Million &amp; Units)

5.1&nbsp;&nbsp;&nbsp; Key trends, product

5.2&nbsp;&nbsp;&nbsp; Immunofluorescence

5.3&nbsp;&nbsp;&nbsp; Chemiluminescence

5.4&nbsp;&nbsp;&nbsp; ELISA (enzyme-linked immunosorbent assay)

5.5&nbsp;&nbsp;&nbsp; Enzyme linked fluorescent system

5.6&nbsp;&nbsp;&nbsp; Multiplexed assay system

5.7&nbsp;&nbsp;&nbsp; Radioimmunoassay

Chapter 6&nbsp;&nbsp;&nbsp;Automated Immunoassay Analyzers Market Size and Forecast, By Application (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, application

6.2&nbsp;&nbsp;&nbsp; Infectious disease

6.2.1&nbsp;&nbsp;&nbsp; Influenza

6.2.2&nbsp;&nbsp;&nbsp; HIV

6.2.3&nbsp;&nbsp;&nbsp; Hepatitis C

6.2.4&nbsp;&nbsp;&nbsp; Sexually Transmitted Disease (STD)

6.2.5&nbsp;&nbsp;&nbsp; Healthcare-Associated Infection (HAI)

6.2.6&nbsp;&nbsp;&nbsp; Respiratory infection

6.2.7&nbsp;&nbsp;&nbsp; Tropical disease

6.2.8&nbsp;&nbsp;&nbsp; Others

6.3&nbsp;&nbsp;&nbsp; Endocrinology

6.4&nbsp;&nbsp;&nbsp; Drug Monitoring

6.5&nbsp;&nbsp;&nbsp; Cardiology

6.6&nbsp;&nbsp;&nbsp; Oncology

6.7&nbsp;&nbsp;&nbsp; Allergy Testing

6.8&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Automated Immunoassay Analyzers Market Size and Forecast, By End-use (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Diagnostic Laboratories

7.4&nbsp;&nbsp;&nbsp; Research and Academic Laboratories

7.5&nbsp;&nbsp;&nbsp; Pharmaceutical and Biotechnology Companies

7.6&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Automated Immunoassay Analyzers Market Size and Forecast, By Region (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; Sweden

8.3.8&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Indonesia

8.4.7&nbsp;&nbsp;&nbsp; Philippines

8.4.8&nbsp;&nbsp;&nbsp; Vietnam

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Columbia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Turkey

8.6.5&nbsp;&nbsp;&nbsp; Israel

8.6.6&nbsp;&nbsp;&nbsp; Iran

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; BioMerieux

9.3&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

9.4&nbsp;&nbsp;&nbsp; Becton Dickinson and Company

9.5&nbsp;&nbsp;&nbsp; Biokit

9.6&nbsp;&nbsp;&nbsp; Carolina Liquid Chemistries Corporation

9.7&nbsp;&nbsp;&nbsp; Inova DX

9.8&nbsp;&nbsp;&nbsp; Luminex Corporation

9.9&nbsp;&nbsp;&nbsp; Meril Life Sciences

9.10&nbsp;&nbsp;&nbsp; Ortho Clinical Diagnostics

9.11&nbsp;&nbsp;&nbsp; Randox Laboratories

9.12&nbsp;&nbsp;&nbsp; Siemens Healthcare

9.13&nbsp;&nbsp;&nbsp; BioRad Laboratories

9.14&nbsp;&nbsp;&nbsp; Aesku Diagnotics

9.15&nbsp;&nbsp;&nbsp; Arlington Scientific

9.16&nbsp;&nbsp;&nbsp; Perkin Elmer

9.17&nbsp;&nbsp;&nbsp; Diasorin 
&nbsp;

Automated Immunoassay Analyzers Market - By Product (Immunofluorescence, Chemiluminescence, ELISA), By Application (Infectious Diseases, Endocrinology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories), & Forecast, 2023 – 2032

Inquiry Before Buying

Industries

Information

Link

Global Headquarters